Compile Data Set for Download or QSAR
Report error Found 8045 with Last Name = 'song' and Initial = 'x'
LigandPNGBDBM15026(N-{5-[(2S)-2-amino-3-phenylpropoxy]pyridin-3-yl}py...)
Affinity DatapH: 7.5 T: 2°CAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15027(5-[(2S)-2-amino-3-phenylpropoxy]-N-(pyridin-4-ylme...)
Affinity DatapH: 7.5 T: 2°CAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15028(5-[(2S)-2-amino-3-phenylpropoxy]-N-(pyridin-3-ylme...)
Affinity DatapH: 7.5 T: 2°CAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15029(3-[(2S)-2-amino-3-({5-[2-(pyridin-4-yl)phenyl]pyri...)
Affinity DatapH: 7.5 T: 2°CAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15041(3-[(2S)-2-amino-3-{[5-(4-nitrophenyl)pyridin-3-yl]...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15045(4-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridi...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15046(4-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridi...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15047(4-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridi...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15048(3-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridi...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
LigandPNGBDBM15052(N-[(4-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]py...)
Affinity DataAssay Description:The kinase assay uses His-Akt1 and a biotinylated peptide as substrate. The biotinylated peptides were immobilized on streptavidin-coated FLASH plat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2007
Entry Details Article
PubMed
TargetApoptosis regulator Bcl-2(Mouse)
Abbvie

US Patent
LigandPNGBDBM178731(US9125913, 300)
Affinity DataAssay Description:The inhibition constant (Ki) is the dissociation constant of an enzyme-inhibitor complex or a protein/small molecule complex, wherein the small molec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2016
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209055(US9266877, 1)
Affinity DataEC50:  425nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209057(US9266877, 3)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209059(US9266877, 5)
Affinity DataEC50:  408nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209063(US9266877, 9)
Affinity DataEC50:  378nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209065(US9266877, 11)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209066(US9266877, 12)
Affinity DataEC50:  51nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209067(US9266877, 13)
Affinity DataEC50:  498nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209068(US9266877, 14)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209069(US9266877, 15)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209071(US9266877, 17)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209072(US9266877, 18)
Affinity DataEC50:  621nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209073(US9266877, 19)
Affinity DataEC50:  398nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209074(US9266877, 20)
Affinity DataEC50:  13nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209075(US9266877, 21)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209076(US9266877, 22)
Affinity DataEC50:  214nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209077(US9266877, 23)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209078(US9266877, 24)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209079(US9266877, 25)
Affinity DataEC50:  377nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209080(US9266877, 26)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209081(US9266877, 27)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209082(US9266877, 28)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209083(US9266877, 29)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209084(US9266877, 30)
Affinity DataEC50:  298nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209085(US9266877, 31)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209086(US9266877, 32)
Affinity DataEC50:  216nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209087(US9266877, 33)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209088(US9266877, 34)
Affinity DataEC50:  907nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209090(US9266877, 36)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209091(US9266877, 37)
Affinity DataEC50:  347nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209092(US9266877, 38)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209093(US9266877, 39)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209094(US9266877, 40)
Affinity DataEC50:  570nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209095(US9266877, 41)
Affinity DataEC50:  11nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209096(US9266877, 42)
Affinity DataEC50:  233nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209097(US9266877, 43)
Affinity DataEC50:  4nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209098(US9266877, 44)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209099(US9266877, 45)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209100(US9266877, 46)
Affinity DataEC50: >1.00E+3nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

TargetBcl-2-like protein 1(Mouse)
Abbvie

US Patent
LigandPNGBDBM209101(US9266877, 47)
Affinity DataEC50:  881nMAssay Description:The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 8045 total ) | Next | Last >>
Jump to: